68 related articles for article (PubMed ID: 7892769)
41. Effect of dotarizine on K(+)-stimulated [3H]-serotonin and [3H]-acetylcholine release from rat hippocampus.
Hadjiivanova C; Petkov VD; Maslarov D; Totev A; Panova Y; Belcheva I
Gen Pharmacol; 1997 Jan; 28(1):129-32. PubMed ID: 9112089
[TBL] [Abstract][Full Text] [Related]
42. Regional differences of cerebrovascular reactivity effected by calcium channel blocker - dotarizine.
Kuridze N; Czernicki Z; Jarus-Dziedzic K; Jurkiewicz J; Cervos-Navarro J
J Neurol Sci; 2000 Apr; 175(1):13-6. PubMed ID: 10785251
[TBL] [Abstract][Full Text] [Related]
43. The effect of Dotarizine--(Ca2+ channel blocker)--on vascular reactivity and ultrastructure of cerebral capillaries in animals subjected to anoxia.
Kuridze N; Gajkowska B; Czernicki Z; Jurkiewicz J; Cervos-Navarro J
Folia Neuropathol; 1998; 36(2):101-8. PubMed ID: 9757621
[TBL] [Abstract][Full Text] [Related]
44. Effects of the Ca2+ channel antagonist flunarizine on visual discrimination learning.
Deyo RA; Hittner JM
Neurobiol Learn Mem; 1995 Jul; 64(1):10-6. PubMed ID: 7582807
[TBL] [Abstract][Full Text] [Related]
45. Vasostabilizing effect of Dotarizine (Ca(2+)-channel blocker) on cerebrovascular reactivity in rabbits.
Kuridze N; Czernicki Z; Jarus-Dziedzic K; Jurkiewicz J; Cervos-Navarro J
Neurol Res; 2000 Mar; 22(2):229-32. PubMed ID: 10763515
[TBL] [Abstract][Full Text] [Related]
46. Effect of dotarizine on CO2-dependent cerebrovascular reactivity.
Chomicki J; Jurkiewicz J; Zabolotny W; Czernicki Z; Cervos-Navarro J
Acta Neurochir (Wien); 1995; 136(3-4):186-8. PubMed ID: 8748852
[TBL] [Abstract][Full Text] [Related]
47. [Evaluation of the biological effects of chemical substances on albino rat offspring].
Rukavishnikov VS; Sosedova LM; Kapustina EA
Gig Sanit; 2011; (6):61-3. PubMed ID: 22250396
[TBL] [Abstract][Full Text] [Related]
48. Neuroendocrine and behavioral effects of flunarizine in young and old rats.
Drago F; Continella G; Mangano O; Canonico PL; Bernardini R; Scapagnini U
Cephalalgia; 1985 May; 5 Suppl 2():125-9. PubMed ID: 4016925
[TBL] [Abstract][Full Text] [Related]
49. Activation of 5-HT7 receptor by administration of its selective agonist, LP-211, modifies explorative-curiosity behavior in rats in two paradigms which differ in visuospatial parameters.
Carbone C; Adinolfi A; Cinque S; Lacivita E; Alleva E; Leopoldo M; Adriani W
CNS Neurosci Ther; 2018 Aug; 24(8):712-720. PubMed ID: 29392842
[TBL] [Abstract][Full Text] [Related]
50. Effect of oral administration of dotarizine on cerebrovasculature subjected to constriction followed by dilatation in rabbits.
Jarus-Dziedzic K; Czernicki Z; Cervos-Navarro J; Jurkiewicz J
Acta Neurochir (Wien); 1999; 141(11):1209-12. PubMed ID: 10592122
[TBL] [Abstract][Full Text] [Related]
51. Antianxiety actions of Ca2+ channel antagonists with Vogel-type conflict test in rats.
Matsumoto Y; Kataoka Y; Watanabe Y; Miyazaki A; Taniyama K
Eur J Pharmacol; 1994 Oct; 264(1):107-10. PubMed ID: 7828638
[TBL] [Abstract][Full Text] [Related]
52. The effect of Dotarizine (Ca2+ channel blocker) on cerebral vessel reactivity in animals subjected to hyperventilation and anoxia.
Czernicki Z; Kuridze N; Jurkiewicz J; Cervós-Navarro J
Acta Neurochir Suppl; 1997; 70():209-11. PubMed ID: 9416324
[TBL] [Abstract][Full Text] [Related]
53. [Effects of prolonged administration of flunarizine in rats].
de Romanis F; Sopranzi N
Clin Ter; 1988 May; 125(4):291-4. PubMed ID: 2974365
[No Abstract] [Full Text] [Related]
54. Memory effects of the Ca2+ and 5-HT antagonists dotarizine and flunarizine.
Petkov VD; Konstantinova E; Petkov VV; Belcheva S; Kehayov R; Vaglenova J
Acta Physiol Pharmacol Bulg; 2000; 25(2):43-50. PubMed ID: 11140170
[TBL] [Abstract][Full Text] [Related]
55. Does nitric oxide participate in the mechanism of action of dotarizine?
Petkov VD; Belcheva S; Konstantinova E; Petkov VV
Acta Physiol Pharmacol Bulg; 1998; 23(3-4):93-9. PubMed ID: 10672335
[TBL] [Abstract][Full Text] [Related]
56. Anxiolytic effects of dotarizine, a possible antimigraine drug.
Petkov VD; Belcheva S; Konstantinova E
Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):659-68. PubMed ID: 9053586
[TBL] [Abstract][Full Text] [Related]
57. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
58. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
de Boer SF; Koolhaas JM
Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
[TBL] [Abstract][Full Text] [Related]
59. Behavioral effects of the Ca2+/5-HT antagonist dotarizine.
Petkov VD; Belcheva S; Konstantinova E; Vaglenova J; Petkov VV
Acta Physiol Pharmacol Bulg; 1994; 20(1):9-17. PubMed ID: 7892769
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
